"The U.S. Food and Drug Administration today approved Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors harbor specific types of epidermal growth factor receptor (EGFR) gene"...
There have been no known cases of XALKORI overdose. There is no antidote for XALKORI.
NoneThis monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/3/2015
Additional Xalkori Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.